Increasing Physical Activity of Patients With Head and Neck Cancer (I-PAP Study)

Head and Neck Cancer Clinical Trial

— I-PAP  

Official title:

Increasing Physical Activity of Patients With Head and Neck Cancer (I-PAP Study)

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT00756795
• Other study ID #: 0053-08-FB
• Status: Withdrawn
• Phase: N/A
• Start date: April 24, 2008
• Est. completion date: August 5, 2010

Study information

• Verified date: August 2023
• Source: University of Nebraska
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Generally, patients who have undergone treatments for Head Neck Cancer have a decreased quality of life and experience depression and fatigue. Regular physical activity improves emotional well-being, increases immunological response, improves wound healing, lessens fatigue and improves general functionality and quality of life. This study will determine effectiveness of the 12-week exercise intervention program, determine if physically active patients differ in quality of life, depression and fatigue during the course of the study, and determine if the change in physical activity levels is related to changes in immune responses.

Description:

The general hypothesis of this research is that patients who have undergone treatments for Head Neck Cancer have a decreased quality of life and experience depression and fatigue. Increasing and sustaining physical activity of these patients will improve their emotional well-beings, increase their immunological response, improve wound healing, lessen fatigue and improve their general functionality and quality of life. The purposes of this study are to: (1) determine the effectiveness of the 12-week exercise intervention program in increasing physical activity in head and neck cancer patients; (2) determine if physically active patients differ in quality of life, depression and fatigue during the course of the study; and (3) determine if the change in physical activity levels is related to changes in the immune responses in human.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: August 5, 2010
• Est. primary completion date: August 5, 2010
• Accepts healthy volunteers: No
• Gender: All
• Age group: 19 Years and older

Eligibility

Inclusion Criteria:

1. Patients 19 years of age or above (Nebraska legal age).

2. Patients diagnosed with HNC who are seen at the University of Nebraska Medical Center.

3. Patients who have undergone chemotherapy, radiation and/or surgery for their cancer.

4. Patients who have completed their cancer treatment at least 3 months prior.

5. Patients who have consented to participate in this study with approval by their physicians.

6. Patients who have no significant mental impairment.

Exclusion Criteria:

1. Patients who are on enteral feeding.

2. Patients who are not able to walk or whose surgeons report that walking is not advisable.

3. Patients diagnosed with Lymphoma, Thyroid cancer or Melanoma.

4. Patients who are on antidepressant medications.

5. Patients who are unwilling to return to the clinic at the end of the study - after 12 weeks of intervention.

6. Patients participating in another research study involving a therapeutic intervention.

7. Patients with chronic medical and orthopedic conditions that would preclude physical activity (e.g., congestive heart failure, recent knee or hip replacements).

8. Patients who are at 18 months or more after the start of cancer treatment.

Related Conditions & MeSH terms

• Head and Neck Cancer
• Head and Neck Neoplasms

Intervention

Behavioral:
• Intervention group
5ml of blood will be collected from each blood draw at baseline and post-intervention to assay for Interleukin-6 level. Structured Interview will be conducted at baseline and post-intervention. Patients assigned to the Intervention group will be given pedometers to obtain distance walked. In addition, patient will be taught how to keep the Exercise diary to record walking and physical activities. All patients will receive 3 reminder phone calls during the first week of study and 10 minutes social visits in the following weeks by study coordinator on a weekly basis.

Locations

Country	Name	City	State
United States	University of Nebraska Medical Center	Omaha	Nebraska

Sponsors (1)

Lead Sponsor	Collaborator
University of Nebraska

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Self-report of physical activity behavior (duration, intensity and frequency)	Participants will be taught how to keep the Activity diary to record walking and physical activities.	Baseline and Post Intervention
Secondary	Plasma IL-6 Concentration	5ml of blood will be collected from each blood draw at baseline and post-intervention to assay for Interleukin-6 level.	Baseline and Post Intervention